Skip to content

One-stage versus two-stage video-assisted thoracic surgery for synchronous bilateral pulmonary nodules: a prospective randomized controlled clinical trial

One-stage versus two-stage video-assisted thoracic surgery for synchronous bilateral pulmonary nodules: a prospective randomized controlled clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500106215
Enrollment
Unknown
Registered
2025-07-21
Start date
2025-07-25
Completion date
Unknown
Last updated
2025-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

One-stage group :Bilateral pulmonary lesions resected in one-stage by minimally invasive surgery
Two-stage group :Bilateral pulmonary lesions resected in two-stage by minimally invasive surgery

Sponsors

Department of Thoracic Surgery, China-Japan Friendship Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Aged 18-75 years; 2.Pathologically or clinically diagnosed with synchronous bilateral non-small cell lung cancer, with at least one surgically indicated lesion in each lung and clinical staging of cT1-2N0-1M0; 3.ASA physical status classification Grade I-II; 4.Charlson Comorbidity Index (CCI) score <= 3; 5.Both bilateral lesions are amenable to minimally invasive surgical resection; 6.Preoperative hematological and cardiopulmonary function assessments within normal ranges, indicating tolerance for bilateral surgical procedures; 7.Signed informed consent form.

Exclusion criteria

Exclusion criteria: 1.Underwent neoadjuvant therapy previously; 2.History of other malignant tumors; 3.Planned bilateral lobectomy; 4.Concomitant severe pulmonary diseases such as pulmonary fibrosis, interstitial pneumonia, or emphysema. Withdrawal criteria: 1. Pathologically confirmed benign, metastatic tumor or small cell lung cancer; 2.Change the surgical plan.

Design outcomes

Primary

MeasureTime frame
Perioperative complication rate within 30 days postoperatively;

Secondary

MeasureTime frame
Surgical time;Blood loss;Duration of chest tube;Length of stay;Pain score;Anxiety and depression scores ;Quality of life score;5-year overall survival;5-year disease free survival;

Countries

China

Contacts

Public ContactHan Yu

China-Japan Friendship Hospital

18818271551@163.com+86 185 1989 0597

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026